Menu
  • Join
  • Login
  • Contact
 

Search abstracts


A Comparative Study on Drug Manufacturing Authorization Systems between China and ICH (International Conference Harmonization) Countries

  • At: 2013 FIP Congress in Dublin (Ireland)
  • Type: Poster
  • By: WANG, Hai Yan (Shandong Food and Drug Administration, Drug Safety Supervision, Jinan, China)
  • Co-author(s): Lin, Bing Yong (Shandong Food and Drug Administration, Jinan, China)
    Li, Yu Ji (Shandong Food and Drug Administration, Jinan, China)
    Xie, Hong Yan (Qilu Pharmaceutical Co., Ltd., Jinan, China)
    Dou, Xue Jie (Shandong Xinhua Pharmaceutical Co., Ltd., Zibo, China)
    Jin, Lian Biao (Meiji Lukang Pharmaceutical Co., Ltd., Jining, China)
  • Abstract:

    Background and aim: The current drug manufacturing authorization system of China is to be upgraded. The comparative study is to provide reference to the revision of the Drug Administration Law of China concerning the drug manufacturing authorization. Methods: Shandong Food and Drug Administration of China established a team and performed a..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses